Craft

SunWay Biotech

Stock Price

NT$90.3

2024-10-29

Market Capitalization

NT$5.4 B

2024-10-29

Revenue

NT$970.2 M

FY, 2024

SunWay Biotech Summary

Company Summary

Overview
SunWay Biotech (三威生物科技股份有限公司) is a manufacturer and seller of R&D and technical materials. It offers soy milk, Sample testing, capsules, powder sachets, tablets, and other products.
Type
Public
Status
Active
Founded
2007
Website
http://sunway.cc
Cybersecurity rating
Sectors

Table of Contents

SunWay Biotech Financials

Summary Financials

Revenue (H1, 2025)
NT$464.4M
Gross profit (H1, 2025)
NT$312.7M
Net income (H1, 2025)
NT$44.1M
Cash (H1, 2025)
NT$680.9M
EBIT (H1, 2025)
NT$59.2M
Enterprise value
$5.2B

Footer menu